ANILINE DERIVATIVES OR SALTS THEREOF AND CYTOKINE PRODUCTION INHIBITORS CONTAINING THE SAME

Details for Australian Patent Application No. 2002216395 (hide)

Owner ISHIHARA SANGYO KAISHA, LTD.

Inventors KATO, Fuminori; KIMURA, Hirohiko; YUKI, Shunji; YAMAMOTO, Kazuhiro; OKADA, Takashi

Pub. Number AU-A-2002216395

PCT Pub. Number WO2002/051397

Priority 2000-391175 22.12.00 JP

Filing date 21 December 2001

Wipo publication date 8 July 2002

International Classifications

A61K 031/167 - having the nitrogen atom of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol

A61K 031/44 - Non-condensed pyridines

A61K 031/4402 - only substituted in position 2, e.g. pheniramine, bisacodyl

A61K 031/4439

A61K 031/4545

A61K 031/505 - Pyrimidines

A61K 031/498 - Pyrazines or piperazines ortho- or peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine

A61K 031/444

A61K 031/5377

A61K 031/496 - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61K 031/5375 - 1,4-Oxazines, e.g. morpholine

C07D 277/66 Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

C07D 213/64 Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 213/70 Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 213/71 Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 213/61 Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 213/76 Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 213/75 Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 239/69 Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 241/44 Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings

C07D 277/62 Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

C07D 277/52 Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

C07D 277/82 Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

C07D 295/12 Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

A61P 043/00 Drugs for specific purposes, not provided for in groups

A61P 037/06 Drugs for immunological or allergic disorders

A61P 037/08 Drugs for immunological or allergic disorders

A61P 017/04 Drugs for dermatological disorders

A61P 011/06 Drugs for disorders of the respiratory system

A61P 027/16 Drugs for disorders of the senses

A61P 027/14 Drugs for disorders of the senses

A61P 027/02 Drugs for disorders of the senses

A61P 029/00 Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 019/02 Drugs for skeletal disorders

A61P 003/10 Drugs for disorders of the metabolism

A61P 021/04 Drugs for disorders of the muscular or neuromuscular system

C07C 233/65 Carboxylic acid amides

C07C 233/75 Carboxylic acid amides

C07C 235/56 Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms

C07C 323/42 Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups

C07C 323/62 Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups

Event Publications

23 January 2003 Application Open to Public Inspection

  Published as AU-A-2002216395

5 February 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002216396-HAIR DRIER HAVING MINUS ION PRODUCER

2002216394-METHOD OF SEPARATING GLYCOLIPIDS